PATENT CLAIM ANALYSIS

Application Number: 15775312
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "234500"]

Abstract:
The present invention relates to a 7-azaindolin-2-one derivative or a pharmaceutically acceptable salt thereof, and the 7-azaindolin-2-one derivative or the pharmaceutically acceptable salt thereof can be favorably used as a medicinal material for inhibiting cancer growth and cancer metastasis.

Claim (Index 3):
The compound or the pharmaceutically acceptable salt thereof according to  claim 1 , wherein R 6  represents:\n hydrogen; or C 1 -C 12  alkyl or C 2 -C 12  alkenyl which is unsubstituted or substituted with C 6 -C 12  aryl, wherein said C 6 -C 12  aryl is unsubstituted or substituted with one or more substituents selected from the group consisting of OH and methoxy; or C 6 -C 12  aryl which is unsubstituted or substituted with one or more substituents selected from the group consisting of halogen, \u2014NO 2 , OH, methoxy, methyl, ethyl, propyl, methylamine, ethylamine, dimethylamine and diethylamine; or C 3 -C 12  heteroaryl containing 1 to 3 heteroatoms which is unsubstituted or substituted with one or more substituents selected from the group consisting of methyl; ethyl; \u2014C(O)OR 15 ; and \u2014C(O)NR 22 R 23 ; R 15  represents hydrogen, methyl or ethyl; R 22  and R 23  each independently represent hydrogen; or methyl or ethyl, which is unsubstituted or substituted with one or more substituents selected from the group consisting of methylamine, ethylamine, dimethylamine, diethylamine and piperidine; or R 22  and R 23  taken together may form cyclohexane, piperazine, piperidine, pyrrolidine or morpholine unsubstituted or substituted with methyl.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.41379
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13196391', '12451466', '12223180', '13945924', '13106076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7966607271392079
- 35 USC 102 Novelty (BERT): 0.5245677117247963
- Combined Prediction Score: 0.7694514255977667
- Mean Citation Score: 311.092622
- Max Citation Score: 313.8167
- Similarity Product: 219.7116587006808

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test